M. Perry

Major histocompatibility complex class II (DR) antigen and costimulatory molecules on in vitro and in vivo activated human polymorphonuclear neutrophils

K. Hill, G. Sandilands, J. McCrae, 2006, Immunology.

PDGF AA as mediator in nicotine-dependent carcinogenesis.

D. Mcintosh, M. Smith, E. Rakowicz-Szulczyńska, 1996, Carcinogenesis.

A Vascular Endothelial Growth Factor Receptor-2 Kinase Inhibitor Potentiates the Activity of the Conventional Chemotherapeutic Agents Paclitaxel and Doxorubicin in Tumor Xenograft Models

M. Batchelor, G. Bignan, M. D'Andrea, 2004, Molecular Pharmacology.

HPA‐1a‐mediated platelet interaction with monocytes in vitro: involvement of Fcγ receptor (FcγR) classes and inhibition by humanised monoclonal anti‐FcγRI H22

T. Keler, E. Wiener, F. Mawas, 2000 .

Nuclear antigens with epitopic homology to the cell surface antigens : the neglected determinants of malignant transformation

D. Mcintosh, E. Rakowicz-Szulczyńska, M. Perry, 1995 .

ANTIGEN RAK : A NEW BREAST CANCER DIAGNOSTIC MARKER

D. Mcintosh, E. Rakowicz-Szulczyńska, M. Perry, 1995 .

Mechanisms of cancer growth promotion by HIV-I neutralizing antibodies

D. Mcintosh, E. Rakowicz-Szulczyńska, M. Perry, 1995 .